Immune cell dysfunction in GI tract may lead to onset of inflammatory bowel disease
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
Mirage News20h
Mount Sinai Uncovers Key Cellular Mechanisms in IBD
A research team led by Mount Sinai has uncovered mechanisms of abnormal immune cell function that may lead to Crohn's disease ...
EurekAlert!2d
Mount Sinai-led team identifies cellular mechanisms that may lead to onset of inflammatory bowel disease
New study shows that dysfunction of protective immune cells in GI tract may contribute to onset of inflammation in Crohn’s disease ...
Armed robbery in Revesby8d
Mount Sinai Unveils Method to Spot Dormant HIV Cells
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Researchers develop method to identify dormant cells that carry HIV
Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...
Personalized cancer vaccine proves promising in a phase 1 trial
Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...
Knowridge Science Report14d
Scientists find hidden genetic cause of congenital heart disease
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new genetic interactions that may contribute ...
Medindia7d
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
News Medical29d
New computational tool iDOMO improves prediction of drug synergy
Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful ... potentially accelerating the discovery of new treatments for a wide range of diseases," Dr. Zhang added.
Personalized Cancer Vaccine Proves Promising in a Phase 1 Trial at Mount Sinai
Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...